Part 3 of 3 – Dr Domenica Lorusso tells us which presentations, in gynecological cancer, she has found particularly interesting at ASCO 2017.
Speaker disclosures: Advisory Board for Clovis Oncology, Astra Zeneca, PharmaMar, Roche.
Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, US, June 2017
Related Videos In Gynecological Oncology
Linda Mileshkin, ESMO 2019 – Phase III OUTBACK trial in cervical cancer
We joined Linda Mileshkin (Peter MacCallum Cancer Centre) following her presentation at ESMO 2019 to discuss the disparities of starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial. Questions 1. Could you tell us a little about the OUTBACK trial and its findings? (0:06) 2. What was […]
Jonathan A Ledermann – Maintenance Treatment for Recurrent Ovarian Carcinoma
Jonathan A Ledermann (UCL Cancer Institute and University College London Hospitals, London, UK) speaks to us around the topic of the review article he recently co-authored entitled: Maintenance Treatment for Recurrent Ovarian Carcinoma – Evidence Supporting the Efficacy and Safety of PARP Inhibitors, which is freely available to access here. Questions 1. For patients with […]
Gloria Huang, ASCO 2019 – NRG Oncology/Gynecologic Oncology Group 210 trial
Gloria Huang discusses results from the NRG Oncology/Gynecologic Oncology Group 210 trial at the ASCO 2019 annual meeting. The trial investigates sex hormone, insulin and insulin-like growth factor signaling in the recurrence of high stage endometrial cancer. Questions 1. What is known about the role of sex hormone, insulin and insulin-like growth factor (IGF) axis […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!